Press release
Eczema Market Intelligence Report Covers Trends, Segments And Regional Growth
Eczema Market
Projected Growth and Market Size of the Eczema Industry by 2030
The eczema market is anticipated to expand substantially, reaching a valuation of $25.98 billion by 2030. This growth corresponds to a compound annual growth rate (CAGR) of 7.8%, fueled by factors such as the adoption of targeted biologics, advances in personalized dermatology treatments, the rise of digital dermatology platforms, increased pediatric care, and improved management of flare-ups related to lifestyle. Key trends during the forecast period include greater use of biologic therapies, heightened demand for topical non-steroidal treatments, rising awareness about chronic skin diseases, expanded pediatric eczema care, and a stronger emphasis on long-term disease control.
The eczema market size has grown strongly in recent years. It will grow from $17.76 billion in 2025 to $19.21 billion in 2026 at a compound annual growth rate (CAGR) of 8.1%. The growth in the historic period can be attributed to atopic dermatitis prevalence, allergen exposure increase, dermatology clinic growth, steroid therapy usage, skincare awareness.
Download a free sample of the eczema market report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=21179&type=smp&utm_source=OpenPR&utm_medium=Paid&utm_campaign=Aug_PR
Leading Companies Driving the Eczema Market Forward
A number of prominent companies are at the forefront of the eczema market, including Pfizer Inc., AbbVie Inc., Bayer AG, Sanofi S.A, Bristol-Myers Squibb Company, AstraZeneca PLC, Novartis AG, GlaxoSmithKline plc, Amgen, Hoffmann-La Roche AG, Eli Lilly and Co., Siemens Healthineers AG, Viatris Inc., Teva Pharmaceutical Industries Ltd., Regeneron Pharmaceuticals Inc., Astellas Pharma Inc., Bausch Health Companies Inc., Galderma, Cadila Pharmaceuticals Ltd., LEO Pharma A/S, Almirall, Kyowa Kirin, Alliance Pharma Plc, Encore Dermatology Inc., and Arcutis Inc.
A notable recent development occurred in May 2024, when Johnson & Johnson acquired Proteologix Inc. for about $850 million. This US-based biotech firm specializes in bispecific antibodies for immune-mediated diseases. The acquisition strengthens Johnson & Johnson's position in treating atopic dermatitis (AD) and asthma by incorporating innovative bispecific antibody therapies into its portfolio.
Emerging Trends Enhancing Treatment Options in the Eczema Market
Companies in the eczema space are increasingly focusing on developing advanced products to meet consumer needs for more effective skincare solutions. One such innovation is eczema care creams designed to soothe and protect sensitive skin by reducing itching, dryness, and inflammation.
For example, in September 2024, Dove, a UK-based personal care company, introduced a new Baby Dove Eczema Care range, including the Soothing Bath Treatment and Eczema Care Cream. These products are formulated with 100% skin-natural nutrients and contain 1.0% colloidal oatmeal, which helps to calm irritation and maintain skin moisture, making them particularly suitable for infants with eczema.
View the full eczema market report:
https://www.thebusinessresearchcompany.com/report/eczema-global-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Aug_PR
Breakdown of Key Segments in the Global Eczema Market
The eczema market is organized into several major segments to provide a comprehensive view:
1) By Type: Atopic Dermatitis, Contact Dermatitis, Seborrheic Dermatitis, Other Types
2) By Treatment Type: Topical Treatments, Oral Medications, Biologics, Phototherapy
3) By Age Group: Children, Adults, Elderly
4) By End User: Hospitals or Clinics, Dermatology Centers, Home Care, Pharmacies
Additional subcategories specify treatment options within types, such as:
- Atopic Dermatitis: Topical Steroids, Topical Calcineurin Inhibitors, Moisturizers, Biologic Therapies
- Contact Dermatitis: Topical Steroids, Antihistamines, Topical Immunosuppressants, Wet Compresses
- Seborrheic Dermatitis: Antifungal Creams or Shampoos, Topical Steroids, Medicated Shampoos, Topical Calcineurin Inhibitors
- Other Types: Allergic Dermatitis, Nummular Dermatitis, Neurodermatitis, Dyshidrotic Eczema
This segmentation enables targeted strategies for addressing various eczema forms and treatment preferences across different patient populations.
Our 2026 reports feature deeper market intelligence with market attractiveness scoring and analysis, total addressable market (TAM) analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics, key technologies and future trend analysis, and updated graphics and tables.
Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Eczema Market Intelligence Report Covers Trends, Segments And Regional Growth here
News-ID: 4606423 • Views: …
More Releases from The Business Research Company
eHealth Market Research Reveals Strong 22% CAGR Outlook Through 2030
The digital health sector is rapidly transforming healthcare delivery worldwide, driven by advancements in technology and increasing demand for accessible, efficient medical services. As the integration of digital tools becomes more widespread, the eHealth market is positioned for remarkable expansion in the coming years. Let's explore the current market size, key players, emerging trends, and the segments fueling this growth.
Projected Growth Trajectory of the eHealth Market
The eHealth market…
Earwax Removal Market Trends Support A 5.8% CAGR Outlook Through The Forecast Pe …
The earwax removal market is on track for notable expansion in the coming years, driven by advancements in technology and shifting consumer preferences. As awareness of safe ear care increases and new products become more accessible, this sector is poised to deliver significant growth and innovation. Let's explore the current market size, key players, segmentation, and emerging trends shaping the future of earwax removal.
Forecasted Market Size Growth for Earwax Removal…
Ear Health Market Report Examines Industry Trends, Growth Drivers And Future Out …
The ear health market is set to experience significant expansion in the coming years, driven by advancements in technology and an increasing focus on preventive ear care. As awareness grows around hearing health and related conditions, this sector is poised to capture greater attention and investment globally. Below is a detailed overview of the market's expected valuation, key players, emerging trends, and segment-wise insights shaping its future.
Projected Market Value and…
Dysphagia Supplement Market Report Examines Leading Companies And Growth Opportu …
The dysphagia supplement market is gaining significant attention as the need for specialized nutritional products grows alongside an aging population and rising chronic disorders. This sector is set to experience notable expansion as healthcare providers and consumers alike seek effective solutions to aid swallowing difficulties. Let's explore the market's size, the main players involved, emerging trends, and the key segments that define this industry.
Projected Market Value and Growth Trajectory for…
More Releases for Eczema
Global Parents for Eczema Research (GPER) Announces 2025 Childhood Eczema Preven …
Santa Barbara, CA, September 9, 2025 - A decade ago, Global Parents for Eczema Research (GPER) was founded with a simple but powerful mission: to reduce the suffering of children with eczema and to give parents a voice in shaping research priorities. Today, GPER is carrying that mission forward by directly funding innovative science to make rapid progress towards a cure and prevention.
GPER is excited to announce the recipients of…
Hand Eczema Market Massive Growth opportunity Ahead
Introduction
Hand eczema, a chronic inflammatory skin condition affecting the hands, is one of the most common occupational skin disorders worldwide. Characterized by itching, redness, scaling, and painful cracks, it can severely impair daily activities and quality of life. The condition is prevalent among healthcare workers, hairdressers, construction workers, and others exposed to irritants and allergens.
With increasing awareness of skin health, growth in dermatological research, and the introduction of novel therapies…
Codex Labs to Exhibit at the National Eczema Association's Eczema Expo 2025
Scottsdale, Ariz. - July 17th, 2025 - Codex Labs [https://www.codexlabscorp.com/], a biotech skincare company focused on microbiome-friendly solutions, is honored to participate in the National Eczema Association's Eczema Expo 2025 [https://nationaleczema.org/eczema-expo/?gad_source=1&gad_campaignid=22351487646&gbraid=0AAAAAB0npNbWbfjE80zPi-DhIw2YfY2qF&gclid=CjwKCAjw3f_BBhAPEiwAaA3K5GPLZHZHEl6Qy8xrAj3hEWhfW7WDsCE-7pymOFKmLfLmr43e1AAXYhoC90YQAvD_BwE]. Taking place from July 24th to 27th at the Grand Hyatt Scottsdale Resort, individuals impacted by eczema will gather to learn from world-class medical experts and community leaders. The goal of the event is to provide you with support,…
Global Parents for Eczema Research (GPER) Awards Two Grants to Advance Childhood …
Santa Barbara, CA, October 15, 2024 - Global Parents for Eczema Research (GPER), a nonprofit organization dedicated to improving the lives of children suffering from eczema (atopic dermatitis, AD), announced the funding of two groundbreaking research projects as part of its 2024 Childhood Eczema Prevention Grant program. These grants will each provide up to $25,000 to support clinical research focused on preventing eczema in children.
Eczema affects up to 20% of…
Global Parents for Eczema Research (GPER) Announces Childhood Eczema Prevention …
Santa Barbara, CA, March 11, 2024 - Global Parents for Eczema Research (GPER) today announced the release of its Childhood Eczema Prevention Grant aimed at supporting innovative research studies focused on preventing pediatric atopic dermatitis (AD or "eczema"). This funding announcement is aimed at addressing the increasing prevalence of AD among children and at fostering research initiatives with the potential to mitigate the burden on children and families.
"We are dedicated…
Eczema Treatment Market During 2017 to 2025
Eczema, also referred as dermatitis or atopic dermatitis, is a disease which results in inflammation of the skin. Eczema is characterized by rash, red skin, and itchiness. The area of the skin involved may vary from small to the entire body. Few combination of factors such as genetical factor, abnormal function of immune system, environmental factor, defects in skin barrier, and activities may cause the skin to be extremely sensitive.…
